Standard
Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study. / Casabonne, Delphine; Benavente, Yolanda; Seifert, Julia; Costas, Laura; Armesto, Maria; Arestin, Maria; Besson, Caroline; Hosnijeh, Fatemeh S.; Duell, Eric J.; Weiderpass, Elisabete; Masala, Giovanna; Kaaks, Rudolf; Canzian, Federico; Chirlaque, Maria-Dolores; Perduca, Vittorio; Mancini, Francesca R.; Pala, Valeria; Trichopoulou, Antonia; Karakatsani, Anna; La Vecchia, Carlo; Sanchez, Maria-Jose; Tumino, Rosario; Gunter, Marc J.; Amiano, Pilar; Panico, Salvatore; Sacerdote, Carlotta; Schmidt, Julie A.; Boeing, Heiner; Schulze, Matthias B.; Barricarte, Aurelio; Riboli, Elio; Olsen, Anja; Tjønneland, Anne; Vermeulen, Roel; Nieters, Alexandra; Lawrie, Charles H.; de Sanjose, Silvia.
In:
International Journal of Cancer, Vol. 147, No. 5, 2020, p. 1315-1324.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Casabonne, D, Benavente, Y, Seifert, J, Costas, L, Armesto, M, Arestin, M, Besson, C, Hosnijeh, FS, Duell, EJ, Weiderpass, E, Masala, G, Kaaks, R, Canzian, F, Chirlaque, M-D, Perduca, V, Mancini, FR, Pala, V, Trichopoulou, A, Karakatsani, A, La Vecchia, C, Sanchez, M-J, Tumino, R, Gunter, MJ, Amiano, P, Panico, S, Sacerdote, C, Schmidt, JA, Boeing, H, Schulze, MB, Barricarte, A, Riboli, E, Olsen, A
, Tjønneland, A, Vermeulen, R, Nieters, A, Lawrie, CH & de Sanjose, S 2020, '
Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study',
International Journal of Cancer, vol. 147, no. 5, pp. 1315-1324.
https://doi.org/10.1002/ijc.32894APA
Casabonne, D., Benavente, Y., Seifert, J., Costas, L., Armesto, M., Arestin, M., Besson, C., Hosnijeh, F. S., Duell, E. J., Weiderpass, E., Masala, G., Kaaks, R., Canzian, F., Chirlaque, M-D., Perduca, V., Mancini, F. R., Pala, V., Trichopoulou, A., Karakatsani, A., ... de Sanjose, S. (2020).
Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study.
International Journal of Cancer,
147(5), 1315-1324.
https://doi.org/10.1002/ijc.32894Vancouver
Casabonne D, Benavente Y, Seifert J, Costas L, Armesto M, Arestin M et al.
Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study.
International Journal of Cancer. 2020;147(5):1315-1324.
https://doi.org/10.1002/ijc.32894Author
Casabonne, Delphine ; Benavente, Yolanda ; Seifert, Julia ; Costas, Laura ; Armesto, Maria ; Arestin, Maria ; Besson, Caroline ; Hosnijeh, Fatemeh S. ; Duell, Eric J. ; Weiderpass, Elisabete ; Masala, Giovanna ; Kaaks, Rudolf ; Canzian, Federico ; Chirlaque, Maria-Dolores ; Perduca, Vittorio ; Mancini, Francesca R. ; Pala, Valeria ; Trichopoulou, Antonia ; Karakatsani, Anna ; La Vecchia, Carlo ; Sanchez, Maria-Jose ; Tumino, Rosario ; Gunter, Marc J. ; Amiano, Pilar ; Panico, Salvatore ; Sacerdote, Carlotta ; Schmidt, Julie A. ; Boeing, Heiner ; Schulze, Matthias B. ; Barricarte, Aurelio ; Riboli, Elio ; Olsen, Anja ; Tjønneland, Anne ; Vermeulen, Roel ; Nieters, Alexandra ; Lawrie, Charles H. ; de Sanjose, Silvia. / Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study. In: International Journal of Cancer. 2020 ; Vol. 147, No. 5. pp. 1315-1324.
Bibtex
@article{fca5724c7fe24b57ba4275a3212fdfdc,
title = "Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study",
keywords = "chronic lymphocytic leukemia, circulating miRNA, serum, prospective study",
author = "Delphine Casabonne and Yolanda Benavente and Julia Seifert and Laura Costas and Maria Armesto and Maria Arestin and Caroline Besson and Hosnijeh, {Fatemeh S.} and Duell, {Eric J.} and Elisabete Weiderpass and Giovanna Masala and Rudolf Kaaks and Federico Canzian and Maria-Dolores Chirlaque and Vittorio Perduca and Mancini, {Francesca R.} and Valeria Pala and Antonia Trichopoulou and Anna Karakatsani and {La Vecchia}, Carlo and Maria-Jose Sanchez and Rosario Tumino and Gunter, {Marc J.} and Pilar Amiano and Salvatore Panico and Carlotta Sacerdote and Schmidt, {Julie A.} and Heiner Boeing and Schulze, {Matthias B.} and Aurelio Barricarte and Elio Riboli and Anja Olsen and Anne Tj{\o}nneland and Roel Vermeulen and Alexandra Nieters and Lawrie, {Charles H.} and {de Sanjose}, Silvia",
year = "2020",
doi = "10.1002/ijc.32894",
language = "English",
volume = "147",
pages = "1315--1324",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "JohnWiley & Sons, Inc.",
number = "5",
}
RIS
TY - JOUR
T1 - Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study
AU - Casabonne, Delphine
AU - Benavente, Yolanda
AU - Seifert, Julia
AU - Costas, Laura
AU - Armesto, Maria
AU - Arestin, Maria
AU - Besson, Caroline
AU - Hosnijeh, Fatemeh S.
AU - Duell, Eric J.
AU - Weiderpass, Elisabete
AU - Masala, Giovanna
AU - Kaaks, Rudolf
AU - Canzian, Federico
AU - Chirlaque, Maria-Dolores
AU - Perduca, Vittorio
AU - Mancini, Francesca R.
AU - Pala, Valeria
AU - Trichopoulou, Antonia
AU - Karakatsani, Anna
AU - La Vecchia, Carlo
AU - Sanchez, Maria-Jose
AU - Tumino, Rosario
AU - Gunter, Marc J.
AU - Amiano, Pilar
AU - Panico, Salvatore
AU - Sacerdote, Carlotta
AU - Schmidt, Julie A.
AU - Boeing, Heiner
AU - Schulze, Matthias B.
AU - Barricarte, Aurelio
AU - Riboli, Elio
AU - Olsen, Anja
AU - Tjønneland, Anne
AU - Vermeulen, Roel
AU - Nieters, Alexandra
AU - Lawrie, Charles H.
AU - de Sanjose, Silvia
PY - 2020
Y1 - 2020
KW - chronic lymphocytic leukemia
KW - circulating miRNA
KW - serum
KW - prospective study
U2 - 10.1002/ijc.32894
DO - 10.1002/ijc.32894
M3 - Journal article
C2 - 32012253
VL - 147
SP - 1315
EP - 1324
JO - International Journal of Cancer
JF - International Journal of Cancer
SN - 0020-7136
IS - 5
ER -
